Emmanuel Tsochatzis

2006–2026 年に発表

173
論文数
21,897
被引用数
75
h 指数
160
i10 指数

被引用数

Emmanuel Tsochatzis の年別被引用数1997 年: 被引用 1 件1998 年: 被引用 1 件2001 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 2 件2007 年: 被引用 2 件2008 年: 被引用 7 件2009 年: 被引用 15 件2010 年: 被引用 26 件2011 年: 被引用 20 件2012 年: 被引用 60 件2013 年: 被引用 67 件2014 年: 被引用 93 件2015 年: 被引用 98 件2016 年: 被引用 93 件2017 年: 被引用 155 件2018 年: 被引用 126 件2019 年: 被引用 653 件2020 年: 被引用 799 件2021 年: 被引用 1,029 件2022 年: 被引用 1,008 件2023 年: 被引用 871 件2024 年: 被引用 1,566 件2025 年: 被引用 949 件2026 年: 被引用 46 件1999〜2000 年は被引用が無いため表示していません2002〜2003 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,662 件、この内訳の 14.5%中国: 引用元論文 1,639 件、この内訳の 14.3%イタリア: 引用元論文 780 件、この内訳の 6.8%イギリス: 引用元論文 755 件、この内訳の 6.6%スペイン: 引用元論文 554 件、この内訳の 4.8%ドイツ: 引用元論文 535 件、この内訳の 4.6%フランス: 引用元論文 414 件、この内訳の 3.6%カナダ: 引用元論文 345 件、この内訳の 3%日本: 引用元論文 292 件、この内訳の 2.5%韓国: 引用元論文 254 件、この内訳の 2.2%インド: 引用元論文 243 件、この内訳の 2.1%スイス: 引用元論文 231 件、この内訳の 2%
0%14.5%その他 33%

分野

  • Medicine87.5%
  • Biochemistry, Genetics and Molecular Biology6.4%
  • Immunology and Microbiology1.8%
  • Nursing0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Agricultural and Biological Sciences0.4%
  • その他2.2%

トピック

  • Liver Disease Diagnosis and Treatment23.2%
  • Liver Disease and Transplantation11.9%
  • Diet, Metabolism, and Disease4.5%
  • Hepatocellular Carcinoma Treatment and Prognosis3.5%
  • Organ Transplantation Techniques and Outcomes3.1%
  • Liver Diseases and Immunity2.9%
  • その他50.9%

共著者

全論文

検索で開く
  1. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

    著者: , , - Metabolism 2016 被引用: 3,060

  2. Advancing the global public health agenda for NAFLD: a consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yusuf Yılmaz, Zobair M. Younossi, Shira Zelber‐Sagi, Fredrik Åberg, Leon A. Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Abdullatif Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramón Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourlière, Radan Brůha, Elisabetta Bugianesi, Patrizia Burra, Marı́a Buti, Christopher D. Byrne, José Luís Calleja, Patrizia Carrieri, Flloyd Carter, Marlén Ivón Castellanos Fernández, Gabriela Castillo-Lopez, Graciela Castro‐Narro, Henry Lik‐Yuen Chan, Wah‐Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen E. Corey, Antonio Craxı̀, Donna R. Cryer, Anuradha Supun Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Lédinghen, Stefano DelPrato, Sandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El‐Kassas, Osama Mohamed Elsanousi, Gamal Esmat, Jian‐Gao Fan, Nathalie J. Farpour‐Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino Alvani Gani, Lynn H. Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon‐Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch ほか 121 名 - Nature Reviews Gastroenterology & Hepatology 2021 被引用: 736

  3. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

    著者: , , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2020 被引用: 760

  4. Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin Kim‐Jun Teh, Carmen Lara‐Romero, Amon Asgharpour, Sara Mahgoub, Mandy Sau-Wai Chan, Clémence M. Canivet, Manuel Romero‐Gómez, Seung Up Kim, Vincent Wai‐Sun Wong, VCTE-Prognosis Study Group - JAMA 2024 被引用: 201

  5. Liver cirrhosis

    著者: , , - The Lancet 2014 被引用: 1,735

  6. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas ほか 130 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 187

  7. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study

    著者: , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2024 被引用: 153

  8. doi:https://doi.org/10.1016/j.jhep.2021.10.025

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - 2021 被引用: 261

  9. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2021 被引用: 289

  10. Steatotic liver disease

    著者: , , , - The Lancet 2024 被引用: 298

  11. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2020 被引用: 243

  12. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , - Journal of Hepatology 2019 被引用: 435

  13. A global research priority agenda to advance public health responses to fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shiv Kumar Sarin, Marcelo Silva, C Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, Juan Pablo Arab, Patrizia Carrieri, Mazen Noureddin, William Alazawi, Naim Alkhouri, Saleh A. Alqahtani, Marco Arrese, Ramón Bataller, Thomas Berg, Paul Brennan, Patrizia Burra, Graciela Castro‐Narro, Helena Cortez‐Pinto, Kenneth Cusi, Nikos Dedes, Ajay Duseja, Sven Francque, Hannes Hagström, Terry T.‐K. Huang, Dana Ivancovsky‐Wajcman, Achim Kautz, Christopher J. Kopka, Aleksander Krag, Veronica Miller, Philip N. Newsome, Mary E. Rinella, Diana Romero, Shiv Kumar Sarin, Marcelo Silva, C. Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Fredrik Åberg, Leon A. Adams, Khalid Al‐Naamani, Reda Albadawy, Zinaida Alexa, Michael Allison, Faisal Abdullatif Alnaser, Khalid Alswat, Mário Reis Álvares‐da‐Silva, Domenico Alvaro, Michele Alves‐Bezerra, Raúl J. Andrade, Quentin M. Anstee, Yaw Asante Awuku, Oidov Baatarkhuu, György Baffy, Shokhista Bakieva, Meena B. Bansal, Robert Barouki, Rachel L. Batterham ほか 241 名 - Journal of Hepatology 2023 被引用: 132

  14. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johannes Wiegand, Thomas Karlas - ˜The œLancet. Gastroenterology & hepatology 2021 被引用: 256

  15. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 207

  16. Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis

    著者: , , , , , , - Gastroenterology 2010 被引用: 1,161

  17. A global action agenda for turning the tide on fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diana Romero, Shiv Kumar Sarin, Marcelo Silva, C Wendy Spearman, Norah A. Terrault, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, on behalf of the Healthy Livers, Healthy Lives Collaborators - Hepatology 2023 被引用: 90

  18. Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rocío Gallego‐Durán, Amon Asgharpour, Kevin Kim‐Jun Teh, Sara Mahgoub, Mandy Sau-Wai Chan, Huapeng Lin, Wen‐Yue Liu, Giovanni Targher, Christopher D. Byrne, Vincent Wai‐Sun Wong, Ming‐Hua Zheng - Gut 2024 被引用: 81

  19. Implementation of a liver health check in people with type 2 diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 60

  20. Non-invasive testing and risk-stratification in patients with MASLD

    著者: , , - European Journal of Internal Medicine 2024 被引用: 94

  21. Defining comprehensive models of care for NAFLD

    著者: , , , , , , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2021 被引用: 148

  22. Consensus Statement on the definition and classification of metabolic hyperferritinaemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Endocrinology 2023 被引用: 100

  23. Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Liver International 2021 被引用: 138

  24. Non-invasive tests for clinically significant portal hypertension after HCV cure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jaime Bosch, Juan Carlos García‐Pagán, Mattias Mandorfer - Journal of Hepatology 2022 被引用: 84